President Biden’s Executive Order issued in 2023 has increased the U.S. government’s engagement with AI across industries, addressing issues such as energy, national security, healthcare, labor concerns, discrimination, cybersecurity, data privacy implications, intellectual property and competition. Called for greater regulation and cooperation, the order directs various departments to develop standards, best practices, and programs to optimize beneficial AI applications, tackle risks, and curb misuse. While promising growth opportunities, this also implies complex compliance challenges for relevant organizations.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
